| Price | $78.11 |
| Year Range | $60.39 – $96.82 |
| Market Cap | $10.4B |
| PE Ratio | 17.78 |
| Industry | Medical Devices |
What Is Globus Medical’s AI Stock Analysis?
Globus Medical’s AI stock analysis on AltIndex combines the company’s fundamentals, price technicals and 25+ alternative data signals — like hiring, web traffic, app downloads and online sentiment — into a single AI Score from 0 to 100 and a plain-English Buy, Hold or Sell read. Unlike a traditional analyst rating that updates a few times a year, the AI Score refreshes as new data arrives, so it tracks Globus Medical’s momentum in near-real time.
Globus Medical (GMED) has an AltIndex AI Score of 54/100, currently a Hold signal. The AI Score distills Globus Medical's fundamentals, price technicals and 25+ alternative data signals into a single 0–100 rating, so a rising score reflects strengthening data across the board and a falling score the opposite.
Globus Medical’s Full AI Analysis
Keep reading AltIndex’s full AI analysis of Globus Medical — the fundamental, technical and alternative-data breakdown and the recommendation.
Sign up to read the full analysisWhat’s Driving GMED’s AI Score?
Fundamentals
Revenue for the last quarter was $760M. This represents a decrease of 8.05% compared to the quarter before it, indicating a need for concern. Compared to the same quarter last year, there is an increase of 27.04%, suggesting positive year-over-year growth. Net income for the last quarter was $124M. This represents a decrease of 11.61% compared to the quarter before it, indicating a need for concern. Compared to the same quarter last year, there is an increase of 64.72%, suggesting positive year-over-year growth. Ebitda for the last quarter was $150M. This represents a decrease of 38.46% compared to the quarter before it, indicating a need for concern. However, compared to the same quarter last year, there is a decrease of 8.38%, which may be a cause for concern. The current P/E ratio is 17.78. This appears to be within a normal range, neither particularly high nor low.
See Globus Medical’s earnings and insider transactions.
Technicals
Today's stock price is $78.11. This represents a decrease of 2.99% compared to a month ago, which may be concerning in the short-term. Compared to a year ago, there is an increase of 36.75%, suggesting a positive long-term trend. The trend is bearish. The current SMA10 is $78.67, which is lower than the previous SMA10 of $78.76. This suggests a potential downward trend in price movement. The RSI is 40, indicating a neutral condition.
See the full technical analysis and price prediction.
Alternative data
Globus Medical has an estimated 335 open positions and this number has been stable over the last couple of months indicating a company in a stable position. The business outlook among employees at Globus Medical is low (an estimate of only 41% of employees have a positive outlook), a concerning sign. Globus Medical has an estimate of 49,000 visitors to their webpage. The number of visitors is down by -27% in the last couple of months, a worrisome trend as this can indicate a loss in customers.
Explore Globus Medical’s job postings, web traffic and app downloads.
Sentiment & social
Globus Medical has 9,100 followers on their Instagram page. The number of followers is up by 7% in the last couple of months, indicating an increased interest in the company. Globus Medical has 1,400 followers on their Twitter page, with no meaningful increase or decrese in the last couple of months.
Track Globus Medical’s market sentiment.
Frequently Asked Questions: Globus Medical AI Stock Analysis
Globus Medical's AltIndex AI Score is 54/100, currently a Hold signal. The AI Score blends fundamentals, technicals and 25+ alternative data signals into a single rating from 0 to 100.
AltIndex's AI Score model rates Globus Medical a Hold (54/100). This is a data-driven signal, not investment advice — review the breakdown above and combine it with your own research.
The AI Score is generated from fundamental data (earnings, valuation), technical indicators (price trend and momentum), and alternative data signals such as hiring, web traffic, app downloads and sentiment. AltIndex weighs these into a single 0-100 score; the exact weighting is proprietary.
AltIndex generates a complete written AI analysis of Globus Medical — company overview, fundamentals, technicals and alternative data, with a recommendation. See the GMED AI Score or sign up to read the full thesis.
